Skip to main content
Surgalign Spine Technologies.
  • Login
  • Investors
    • Financials
    • Governance
    • Investors Overview
    • Newsroom
    • Stock
  • Choose a language for this website. English
    • English
    • Deutsch
    • English (EU)
  • Surgalign Spine Technologies.
  • Company

    • Executive Leadership
    • Board of Directors
    • Corporate Compliance
    • Company Credentials
    • Careers
    • Events
    • Contact Us
    • About Us
    About Us

    Learn how we are striving every day to deliver MORE THAN POSSIBLE.™

    Our Story
  • Contact Us

Latest News

July 28, 2023
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales
June 23, 2023
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
June 20, 2023
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code
May 23, 2023
Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources
May 11, 2023
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
May 08, 2023
Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research
May 04, 2023
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023
May 03, 2023
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies
April 13, 2023
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance
March 30, 2023
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
View All News

eIFU | Symbols Glossary

Surgalign-Logo_Reversed_Alone
Terms of Use Web Privacy Policy and Transparency Disclosure Notice
© 2023 Surgalign Spine Technologies, Inc. All rights reserved.